Dr Reddy's Labs shares in focus after Q4 profit jumps 22% to Rs 1,594 crore
.jpg "Autor")
Finance news:
Dr Reddy's Labs shares in focus after Q4 profit jumps 22% to Rs 1,594 crore
Dr Reddy's Laboratories shares will be in focus on Monday after the company reported a 22% year-on-year rise in consolidated net profit to Rs 1,594 crore for the January–March quarter of FY25, up from Rs 1,307 crore in the same period last year। ETMarkets। com Dr Reddy's Labs shares: The company posted a 22% year-on-year increase in consolidated net profit, reaching Rs 1,594 crore। The pharma major's revenue from operations in the March-ended quarter stood at Rs 8,506 crore, which was up 20% versus Rs 7,083 crore in the corresponding quarter of the last financial year। Profit after tax (PAT) was up 13% quarter-on-quarter versus Rs 1,413 crore in Q3FY25। All profits are attributable to the company's equity holders। The topline surged 1। 8% sequentially over Rs 8,359 crore reported in the October-December quarter of FY25। Also Read: Stocks in news: Tata Steel, Swiggy, Dr Reddy's, Cyient DLM, Thermax, Adani Power Live Events In its global generics business, North America contributed revenue of Rs 3,559 crore, witnessing a 9% growth। The European business revenue jumped 145% to Rs 1,275 crore। This included revenues from the acquired NRT business of Rs 597 crore for Q4FY25। The India business revenue grew 16% YoY to Rs 1,305 crore from Rs 1,126 crore in Q4FY24। Company's Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) stood at Rs 2,475 crore in the quarter under review which was 29% of the revenues। The pharmaceutical services & Active Ingredients (PSAI) also recorded a 16% YoY growth at Rs 956 crore versus Rs 822 crore in the year ago period। Also Read: 5 timeless Warren Buffett quotes every investor should know Management take Commenting on the results, Co-Chairman & MD, G V Prasad said that the company achieved double-digit growth across our businesses, driven by successful product launches, increased revenues from key products in the US and the integration of the acquired NRT business। "We will continue to strengthen and grow our core businesses through portfolio management and operational," he said। Dr Reddy's Laboratories shares price target As per Trendlyne data, the average target price of the stock is Rs 1,320, which shows an upside of 14% from the current market prices। The consensus recommendation from 38 analysts for the stock is a 'Hold'। ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own। These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel ) Read More News on dr reddy's laboratories dr reddy's labs shares dr reddy's labs share price dr reddy's labs q4 results markets news Dr Reddy's Laboratories consolidated net profit pharmaceutical revenue growth North America generics revenue stock price target (What's moving Sensex and Nifty Track latest market news , stock tips , Budget 2025 , Share Market on Budget 2025 and expert advice , on ETMarkets । Also, ETMarkets। com is now on Telegram। For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds । ) Subscribe to ET Prime and read the Economic Times ePaper Online। and Sensex Today । Top Trending Stocks: SBI Share Price , Axis Bank Share Price , HDFC Bank Share Price , Infosys Share Price , Wipro Share Price , NTPC Share Price । more less (You can now subscribe to our ETMarkets WhatsApp channel ) Read More News on dr reddy's laboratories dr reddy's labs shares dr reddy's labs share price dr reddy's labs q4 results markets news Dr Reddy's Laboratories consolidated net profit pharmaceutical revenue growth North America generics revenue stock price target (What's moving Sensex and Nifty Track latest market news , stock tips , Budget 2025 , Share Market on Budget 2025 and expert advice , on ETMarkets । Also, ETMarkets। com is now on Telegram। For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds । ) Subscribe to ET Prime and read the Economic Times ePaper Online। and Sensex Today । Top Trending Stocks: SBI Share Price , Axis Bank Share Price , HDFC Bank Share Price , Infosys Share Price , Wipro Share Price , NTPC Share Price । more less Prime Exclusives Investment Ideas Stock Report Plus ePaper Wealth Edition Despite losing market share, why BigBasket is still a good bet Godfrey Phillips is up 63% this year। Why the market feels this smoke still has fire Why IMF’s USD2। 4 billion dole can’t bring a beyond-repair Pak economy back on track As US-China tariff war continues, container shipping sees record high voyage cancellations Awfis underperforms despite high MF interest। What’s capping its growth? Multibagger or IBC (Series: AA 125), Part 5: This company, at the right place at the right time 1 2 3 View all Stories।
Posted on 12 May 2025 | Follow HeadlinesNow.com for the latest updates.
Post a Comment